UiPath (PATH.US) Price Target and Rating 2026/2027

13,84
0,14%
Price history for UiPath (PATH.US) – stock price at 13.84 $, August 2026
UiPath stock price – price development 2026. Updated Aug 6, 2026.
Share this analysis:

UiPath Price Target 2026: Analysts See 4% Downside

The average price target for UiPath is $13.25. This price target represents the analysts' view of the stock price over the next 12 months. The stock appears overvalued, because the price target is lower than the current price. It is -4,26% above the target, and analysts expect the price to fall over the next 12 months. Even if the stock may be overvalued, price momentum can last longer than expected. That is why it is important to keep an eye on the stock and its momentum on an ongoing basis. WallStreetBuys helps you with the technical analysis and keeps you up to date on the development.

Is UiPath overvalued or undervalued?

UiPath is currently fairly valued with a gap of 4.3% relative to the price target.


The current price is $13.84, which places UiPath in the fairly valued category. The stock is considered undervalued when the price is below $11.93, and overvalued when the price exceeds $14.58.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For UiPath, the fair value range lies between $11.93 and $14.58.


See the full price target analysis for UiPath →

Analyst Ratings for UiPath stock in 2026: Hold

24 analysts cover UiPath. Analysts are mostly neutral — 75% recommend Hold. The average price target is $13.25, which is 4.3% below the current price.

Consensus: Hold (3.17/5)
Strong Buy
3 (12.5%)
Buy
1 (4.2%)
Hold
18 (75%)
Sell
1 (4.2%)
Strong Sell
1 (4.2%)
Strong Sell Sell Hold Buy Strong Buy
3.17 out of 5 based on 24 analysts

About UiPath – Software - Infrastructure

UiPath laver en platform, der automatiserer kedelige opgaver i virksomheder. De sælger software, som bruger robotter og kunstig intelligens til at strømline processer. Kort sagt, de hjælper med at bygge, styre og køre automatisering internt. De tjener penge på at tilbyde en række forbundne værktøjer, der lader folk uden kodekendskab udvikle automatiseringer. Platformen kombinerer AI med systemlogfiler for at finde de processer, der giver mest mening at automatisere. UiPath er især store i USA, Rumænien og Japan. De er kendt for deres RPA-løsninger (Robotic Process Automation). Virksomheden blev grundlagt i 2005 og har i dag over 4.000 ansatte, der driver denne globale forretning. Read more about the company

Key Figures for UiPath

$ 7,3B Market cap
$ 1,7B Revenue
Software - Infrastructure Industry
23.11 P/E
4.37 P/S
3.47 P/B
USA Listed on exchange
uipath.com Website

What kind of stock is UiPath?

Growth stock

UiPath is classified as a growth stock with quarterly earnings growth of 105.7% and strong long-term momentum of 0.0%.

Score Overview for UiPath

💰 Value Score 51/100 (Neutral)
⭐ Quality Score 53/100 (Neutral)
🚀 Momentum Score 44/100 (Neutral)
📊 Total Score 49/100

⚠️ 1 red flag identified 1 critical

Our analysis has identified 1 potential risk factor in UiPath that investors should be aware of.

🚨 High short interest: 28.1% of the shares are sold short – many professional investors are betting on price declines.

📈 Valuation

UiPath trades at a P/E ratio of 23.1, which is close to the market average. The forward P/E is 16.1 (31% lower), which suggests the market expects rising earnings. The P/S ratio is 4.4. The P/B ratio is 3.5. The PEG ratio is 0.46 — below 1.0 suggests the stock is cheap relative to its growth rate.

💵 Profitability & Growth

UiPath has a profit margin of 19.6% (solid) and an operating margin of 7.3%. Return on equity (ROE) is 18.2% — solid return on equity. Return on assets (ROA) is 2.4%. The latest quarterly earnings grew 105.7% year over year — strong growth.

🏦 Financial Health

The Piotroski score is 6 out of 9 — good financial health. Altman Z2 is 2.69 (healthy balance sheet — low risk). The debt-to-equity ratio (D/E) is 55.2% — low debt, a solid balance sheet.

🚀 Momentum & Short Interest

Short interest is 28.11% — very high, the market is skeptical.

Insider Trading in UiPath 2026: The Signal Is negative

In 2026, insiders at UiPath have made 20 transactions, all of which were sales. On a net basis, insiders took 11,888,499 $ out of the stock. Active insiders include Ramani Hitesh, Malpani Raghavendra, Gupta Ashim and others. In the short term (last 3 months), the insider signal is negative.

Short-Term Signal (3 months): Negative

Insiders have exclusively sold shares over the last 3 months.

Over the last 3 months: 0 purchases and 4 sales. A net 237,999 $ out of the stock.

Long-Term Signal (all transactions): Negative

Insiders have exclusively sold shares in the recent period. This can suggest management sees limited opportunity.

Across the last 20 transactions: 0 purchases and 20 sales. A net 11,888,499 $ out of the stock.

Latest sale: Ramani Hitesh sold 1,323 shares at 11 $ each on 2026-07-01.

Who is selling: Ramani Hitesh, Malpani Raghavendra, Gupta Ashim, Brubaker Brad, Dines Daniel and others.

Latest Insider Trades in UiPath (2026)

The table shows the last 20 reported insider transactions in UiPath. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-07-01 Ramani Hitesh Sell 1,323 11 14,381
2026-07-01 Malpani Raghavendra Sell 2,095 11 22,773
2026-07-01 Gupta Ashim Sell 12,266 11 133,331
2026-07-01 Brubaker Brad Sell 6,211 11 67,514
2026-01-26 Dines Daniel Sell 45,000 15 675,450
2026-01-26 Daniel Dines Sell 45,000 15 675,450
2026-01-23 Dines Daniel Sell 45,000 15 685,350
2026-01-22 Dines Daniel Sell 45,000 15 675,900
2026-01-22 Daniel Dines Sell 45,000 15 675,900
2026-01-15 Dines Daniel Sell 45,000 15 692,100

Who is buying and selling UiPath shares in 2026?

The following insiders have sold shares: Ramani Hitesh, Malpani Raghavendra, Gupta Ashim, Brubaker Brad, Dines Daniel and others. In total, 11,888,499 $ was sold across 20 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

UiPath Short Selling 2026: 28.1% Sold Short

Extremely shorted: 28.1% of the free float
Short % of free float
28.1%
Assessment
Extremely shorted
Short squeeze risk
Very High
Data source
SEC
Updated daily
The stock has an extremely high share of short selling. More than 20% of the freely traded shares are sold short, which is unusual and can point to great skepticism among institutional investors. The risk of a short squeeze on positive news is considerable.

What does this mean for you as an investor?
A short interest of 28.1% means that 28.1% of the freely traded shares in UiPath have been borrowed and sold by investors betting on falling prices. On positive surprises (e.g. a strong earnings report), short sellers can be forced to buy back shares quickly to close their positions, which can cause a short squeeze with sharp price gains in a short time.

The next potential catalyst is the earnings report on 9/3/2026. With a short interest of 28.1%, the report can trigger considerable volatility.

Data is updated daily based on official filings with the SEC.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
28.1%

When Does UiPath Report Earnings – Next Date: 9/3/2026

The next earnings report from UiPath is scheduled for September 3, 2026, after the market closes. This report covers the third quarter (Q3), which ended on July 31, 2026.



Technical Analysis of UiPath 2026 – Signal: Buy

Overall Technical Signal: Buy

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated August 6, 2026.

Technical analysis of UiPath (PATH.US) – RSI 68, MACD positive (bullish), daily candlestick chart August 2026
UiPath technical analysis – candlestick chart with RSI and MACD. Updated Aug 6, 2026.

Trend Analysis of UiPath Inc

UiPath Inc is in a short-term uptrend. The price of $13.82 is 14.3% above the 20-day average ($12.09). Medium term, the picture is positive: the price is 20.4% above the 50-day average ($11.48). Long term, the stock is 8.4% above the 200-day average ($12.75), which confirms a long-term uptrend.

Death Cross: The 50-day average (11.48) is below the 200-day average (12.75), which is a classic bearish signal for UiPath Inc.

Is UiPath Inc overbought or oversold?

UiPath Inc has an RSI of 67.6. The stock shows positive momentum in the upper part of the neutral zone. Combined with the positive trend, this supports the bullish picture.

MACD Analysis for UiPath Inc

Daily MACD: MACD is positive (0.574), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is above the signal line (0.345) by 0.229, which confirms rising momentum in the uptrend.

Weekly MACD: MACD5 is negative (-0.167), which indicates a broader bearish long-term trend. MACD5 is above the signal line (-0.519) by 0.352, which suggests the negative long-term momentum is fading – a bigger trend reversal could be ahead.

Overall MACD assessment: The daily and weekly MACD give conflicting signals. The short-term trend is bullish, but the long-term trend is still bearish. Weekly momentum is rising, though, which could signal an upcoming trend reversal.

Risk Profile for UiPath Inc

UiPath Inc has an annual standard deviation of 66.5%, which classifies the stock as high risk. Sizeable price swings are normal, and the stock requires a higher risk tolerance.

Overall Technical Conclusion for UiPath Inc

Trend: Positive. The price trades above SMA50 and SMA200.

MACD trend (zero line): Daily bullish (0.574). Weekly bearish (-0.167).

MACD momentum (signal): Daily rising. Weekly rising.

RSI: 67.6 – neutral.

Technical signal: Buy

The broader trend is positive and MACD supports the picture. Consider buying with a stop-loss below the nearest support level.

Frequently Asked Questions About UiPath stock in 2026

Should you buy UiPath stock now?
Yes, the technical signal for UiPath is currently BUY. UiPath trades at $13.84 as of 8/6/2026. The overall technical signal is: Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 0.574 with rising momentum (signal: 0.345); RSI is at 67.6 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $13.25 is 4.3% below the current price. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for UiPath stock?
The average analyst price target for UiPath is $13.25. The current price is $13.84, which gives a downside of 4.3%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $11.93 and $14.58.
Is UiPath a dividend stock?
No, UiPath does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of UiPath stock?
UiPath is rated as a stock with high risk. the annual standard deviation is 66.5%, which classifies the stock as high risk.
Is UiPath overvalued?
UiPath is considered fairly valued – the price is close to the analyst price target. UiPath has the following valuation ratios: a P/E ratio of 23.1 (moderately to highly valued), a P/S ratio of 4.4, a P/B ratio of 3.5. The stock trades close to the analyst price target and is considered fairly valued.
Is UiPath overbought?
No, UiPath is not overbought. RSI is at 67.6 (neutral zone). The technical indicators show: RSI is at 67.6 (upper neutral zone), which shows positive momentum but is not yet overbought. In addition, the price is 14.5% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next UiPath earnings report?
UiPath reports its next earnings on September 3, 2026. The stock currently trades at $13.84. With a P/E ratio of 23.1, the market will be watching closely whether earnings meet expectations. The RSI is at 67.6, so the report can reinforce the current technical trend.
Is UiPath shorted?
Yes, UiPath is shorted with 28.1% of the free float sold short. This is an extremely high level of short selling, which points to great skepticism among institutional investors. The risk of a short squeeze on positive news or earnings is very high. Data is updated daily based on official filings with the SEC.
Are insiders buying UiPath stock?
No, insiders are not buying UiPath shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 4 sales. On a net basis, 237,999 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 11,888,499 $ sold. Active sellers include Ramani Hitesh, Malpani Raghavendra, Gupta Ashim and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is UiPath a good stock?
Based on our total score, UiPath is rated as a mediocre stock with a total score of 49 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 51/100, Quality: 53/100, Momentum: 44/100. In addition: technical signal: Buy. Whether UiPath is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for UiPath stock?
The outlook for UiPath based on current data: the average analyst price target is $13.25 (-4.3%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on 9/3/2026, which can move the price; the P/E ratio is 23.1 (moderate). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is UiPath stock rising?
UiPath is rising right now. The technical indicators show: the price is 14.5% above the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 28.1% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can UiPath go?
The average analyst price target for UiPath is $13.25, which is 4.3% below the current price of $13.84. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can UiPath fall?
We lack enough history to give a specific floor for UiPath. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does UiPath do?
UiPath laver en platform, der automatiserer kedelige opgaver i virksomheder. De sælger software, som bruger robotter og kunstig intelligens til at strømline processer. Kort sagt, de hjælper med at bygge, styre og køre automatisering internt. De tjener penge på at tilbyde en r... The company belongs to the Teknologi sector, more specifically the Software - Infrastructure industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate UiPath as an investment.
Did UiPath raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from UiPath. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is UiPath making money or losing money?
Yes, UiPath is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 19.6% — which is solid. The operating margin (profit before interest and taxes) is 7.3%. At a P/E ratio of 23.1, you currently pay 23.1 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can UiPath go bankrupt?
The bankruptcy risk of UiPath is rated as low. Altman Z2 (a model for assessing financial distress) is 2.69 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 6 — which is average. Debt relative to equity is 55% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does UiPath have a lot of debt?
No, UiPath has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 55%. For the teknologi sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.